VLA 0.00% $1.75 viralytics limited

re: Ann: CAVATAK anti-cancer activity - US Ca... phMurhpy,I...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,050 Posts.
    lightbulb Created with Sketch. 77
    re: Ann: CAVATAK anti-cancer activity - US Ca... phMurhpy,

    I hadn't had chance to compare data with previous results - but I thought success was higher. So thanks to you 2 posters for confirming.

    So its a question of just how representative the batch of patients being used in VLA trials are - compared to average cancer patient - as to assessing general potential of Cavatak.

    However, given the number of variables between patients, the 'success" rate is holding up amazingly well - such that optimism must be increasing exponentially with every good result being reported.

    On another matter, I was lucky enough to get more shares than I was entitled to.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.